Fair value (multi-method)
Four independent methods triangulate what BSX is worth. The headline is the Forward-DCF intrinsic value at a normalized growth rate; the margin of safety compares it to the current price.
Estimated fair value (Forward DCF)
$20.27
Method range
$18.78 – $191.43
median $49.13
Valuation methods
Each method’s implied fair value per share and its upside versus the current price. Missing methods (no analyst coverage, negative earnings, etc.) are shown as “—”.
| Method | Fair value | Upside vs price |
|---|---|---|
| Forward DCF | $20.27 | -52.83% |
| Exit multiple | $191.43 | +345.50% |
| Analyst target | $78.00 | +81.52% |
| Graham number | $18.78 | -56.28% |
- Forward DCF$20.27
- Exit multiple$191.43
- Analyst target$78.00
- Graham number$18.78
Stock price
$42.97
FCF / share (TTM)
$0.12
3Y FCF CAGR
27.8%
Fair value @ hist. growth
$16.44
This analysis is for informational purposes only and is not financial advice. Scenario prices and DCF-style figures depend on your assumptions and data from public filings and estimates. They are not forecasts of future returns.
Implied FCF growth
41.4%
per year over your projection horizon
Margin of safety -161.4% vs hist-growth DCF
Historical 3Y CAGR
27.8%
Your model implies
41.4%
Analyst consensus is EPS-only — no comparable FCF / share estimate to show on this basis.
Model inputs
Move sliders to test how the reverse DCF reacts. Historical-growth markers show where the company has actually grown over the last cycle.
Undiscounted FCF per share over 10 years at 28% annual growth.
Sensitivity — implied growth vs your assumptions
Each cell shows the per-share growth rate the market would need to justify the current price at that combination of discount rate (rows) and terminal growth (columns). Your selected inputs are highlighted.
| Row axis: discount rate. Column axis: terminal growth.Terminal g →↓ Discount | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 5.6% | 36.2% | 34.6% | 32.7% | 30.4% | 27.8% |
| 6.6% | 40.2% | 38.9% | 37.4% | 35.7% | 33.8% |
| 7.6% | 43.8% | 42.6% | 41.4% | 40.1% | 38.6% |
| 8.6% | 47.0% | 46.0% | 45.0% | 43.8% | 42.6% |
| 9.6% | 50.0% | 49.1% | 48.2% | 47.2% | 46.2% |
Historical multiples
Each bar is the trailing five-year range (low left, high right). Filled portion runs from low to today; the dot marks today; the small tick marks the five-year median. Low, median, and high are listed under each bar.
PEG
0.17
Low vs growth
Net debt
$10.4B
Total debt − cash
Beta
0.58
Vs market benchmark
Frequently asked questions
Boston Scientific (BSX) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.